Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination therapies for COVID‐19: An overview of the clinical trials landscape
Sola Akinbolade, Diarmuid Coughlan, Ross Fairbairn, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 4, pp. 1590-1597
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Accurate and interpretable drug-drug interaction prediction enabled by knowledge subgraph learning
Yaqing Wang, Zhimu Yang, Quanming Yao
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 13
COVID-19 therapeutics
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 12
Unpacking the sepsis controversy
John C. Alverdy
Trauma Surgery & Acute Care Open (2025) Vol. 10, Iss. 1, pp. e001733-e001733
Open Access | Times Cited: 1
A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein
Ellen Van Damme, Pravien Abeywickrema, Yanting Yin, et al.
Nature (2025)
Open Access | Times Cited: 1
Efficacy and safety of sotrovimab in patients with COVID‐19: A rapid review and meta‐analysis
Bahman Amani, Behnam Amani
Reviews in Medical Virology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 30
Antiviral combination therapies for persistent COVID-19 in immunocompromised patients
Daniele Focosi, Fabrizio Maggi, Alessandra D’Abramo, et al.
International Journal of Infectious Diseases (2023) Vol. 137, pp. 55-59
Open Access | Times Cited: 19
GabaAergic sedative prospection of sclareol-linalool co-treatment: An antagonistic intervention through in vivo and in silico studies
Muhammad Torequl Islam, Md. Sakib Al Hasan, Jannatul Ferdous, et al.
Neuroscience Letters (2024), pp. 138060-138060
Closed Access | Times Cited: 6
Pulmonary surfactant as a versatile biomaterial to fight COVID-19
Lore Herman, Stefaan C. De Smedt, Koen Raemdonck
Journal of Controlled Release (2021) Vol. 342, pp. 170-188
Open Access | Times Cited: 28
UV 254 nm is more efficient than UV 222 nm in inactivating SARS-CoV-2 present in human saliva
Renata Sesti‐Costa, Cyro von Zuben de Valega Negrão, Jacqueline Farinha Shimizu, et al.
Photodiagnosis and Photodynamic Therapy (2022) Vol. 39, pp. 103015-103015
Open Access | Times Cited: 22
Pharmacokinetic considerations for enhancing drug repurposing opportunities of anthelmintics: Niclosamide as a case study
Jeong In Seo, Geun‐woo Jin, Hye Hyun Yoo
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116394-116394
Open Access | Times Cited: 4
A novel multitargeted self-assembling peptide-siRNA complex for simultaneous inhibition of SARS-CoV-2-host cell interaction and replication
Martina Tuttolomondo, Stephanie Thuy Duong Pham, Mikkel G. Terp, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102227-102227
Open Access | Times Cited: 4
Caffeine and sclareol take the edge off the sedative effects of linalool, possibly through the GABAA interaction pathway: molecular insights through in vivo and in silico studies
Muhammad Torequl Islam, Md. Sakib Al Hasan, Jannatul Ferdous, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Plant Spices as a Source of Antimicrobial Synergic Molecules to Treat Bacterial and Viral Co-Infections
Nathália Barroso Almeida Duarte, Jacqueline A. Takahashi
Molecules (2022) Vol. 27, Iss. 23, pp. 8210-8210
Open Access | Times Cited: 10
A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein
Marnix Van Loock, Ellen Van Damme, Pravien Abeywickrema, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Spectroscopic characterization and quantum chemical calculations on Favipiravir-Guanine biomolecular complex
Jyotshna Saikia, Neelam Chetry, Th. Gomti Devi
Spectroscopy Letters (2024) Vol. 57, Iss. 5, pp. 300-323
Closed Access | Times Cited: 1
Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single center study.
Ivan Gentile, Giulio Viceconte, F. M. Cuccurullo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
Frauke Assmus, Jean‐Sélim Driouich, Rana Abdelnabi, et al.
Microorganisms (2022) Vol. 10, Iss. 8, pp. 1639-1639
Open Access | Times Cited: 6
Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications
Ching-Tse Ting, Bor‐Sen Chen
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3649-3649
Open Access | Times Cited: 5
Reaching the Final Endgame for Constant Waves of COVID-19
Norman A. Ratcliffe, Helena Carla Castro, Marcelo Salabert Gonzalez, et al.
Viruses (2022) Vol. 14, Iss. 12, pp. 2637-2637
Open Access | Times Cited: 5
Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment
Noha Samir Taibe, Maimona A. Kord, Mohamed A. Badawy, et al.
Therapeutic Advances in Respiratory Disease (2022) Vol. 16
Open Access | Times Cited: 4
Computational pharmacology: New avenues for COVID-19 therapeutics search and better preparedness for future pandemic crises
Austė Kanapeckaitė, Asta Mažeikienė, Liesbet Geris, et al.
Biophysical Chemistry (2022) Vol. 290, pp. 106891-106891
Open Access | Times Cited: 3
Specific binding of G-quadruplex in SARS-CoV-2 RNA by RHAU peptide
Le Tuan Anh Nguyen, Thao Nguyen, Dung Thanh Dang
Current Research in Structural Biology (2024) Vol. 7, pp. 100126-100126
Open Access
Editorial: The evolution in pharmacology of infectious diseases: 2022
Exequiel O. J. Porta, Ali Saffaei, Karunakaran Kalesh
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Caffeine and sclareol reduce the sedative effects of linalool, possibly through the GABA A interaction pathway: molecular insights through in vivo and in silico studies
Muhammad Torequl Islam, Md. Sakib Al Hasan, Jannatul Ferdous, et al.
Research Square (Research Square) (2024)
Closed Access
Page 1 - Next Page

Scroll to top